期刊文献+

中国产3种柑桔类果汁对阿托伐他汀人体内药动学影响的研究

Effects of Three Kinds of Juice of Mandarinorange on Pharmacokinetics of Atorvastatin in Healthy Volunteers
原文传递
导出
摘要 目的观察反复摄入3种柑桔类果汁对阿托伐他汀(ATV)在健康受试者体内药动学的影响。方法采用4周期交叉自身对照试验设计,洗脱期为2周。24名健康受试者随机分为4组,每组6人,分别给予220 mL葡萄柚汁,220 mL橙汁,220 mL桔汁和220 mL水,1 d 3次,共服用2 d。于第3天分别用220 mL葡萄柚汁,220 mL橙汁,220 mL桔汁和220 mL水送服单剂量10 mg ATV片,服药后0.5和1.5 h再分别服用220 mL葡萄柚汁,220 mL橙汁,220 mL桔汁和220 mL水,于服药后48 h内检测ATV血浆浓度。结果与对照组水相比,服用葡萄柚汁使阿托伐他汀酸的AUC0-∞增加8%(P>0.05),ρmax降低8%(P>0.05);服用橙汁使阿托伐他汀酸的AUC0-∞降低10%(P>0.05),ρmax降低27%(P>0.05);服用桔汁使阿托伐他汀酸的AUC0-∞降低13%(P>0.05),ρmax降低15%(P>0.05)。结论3种果汁未显著影响健康受试者体内ATV的药动学过程。 OBJECTIVE To investigate the effects of three kinds of juices of maudarinorange on the pharmacokinetics of atorvastatin in healthy volunteers. METHODS A self-controlled, crossover study was designed with four phases and a washout period of 2 weeks. 24 Healthy volunteers were divided into 4 groups randomly, 6 in each group. For 2 d prior to the study-drug administration, 220 mL of grapefruit juice( GFJ), sweet orange juice, mandarin orange juice or water was given to volunteers of each group three times daily. On the third day, a single dose of 10 mg atorvastatin was orally administered with GFJ, sweet orange juice, mandarin orange juice or water. The additional 220 mL of GFJ, sweet orange juice, mandarin orange juice or water was taken at 0. 5 and 1.5 h after administration of atorvastatin. The plasma concentration of atorvastatin was determined at 48 h after dosing. RESULTS Compared with the water group, the AUC0-∞ of atorvastatin acid was increased by 8% ( P 〉 0.05 ) , Pmax was decreased by 8% ( P 〉 0.05 ) ,in the group treated with GFJ ; the AUC0-∞ and Pmax of atorvastatin acid group were decreased by 10% ( P 〉 0. 05 ) and 27% ( P 〉 0. 05 ) in the group treated with sweet orange juice ; the AUC0-∞ and Pmax of atorvastatin acid were decreased by 13% ( P 〉 0. 05 ) and 15% ( P 〉 0. 05 ) in the group treated with mandarin orange juice. CONCLUSION Three kinds of juice showed no significantly influence on the pharmacokinetics of atorvastatin in healthy subjects.
出处 《中国药学杂志》 CAS CSCD 北大核心 2010年第3期206-210,共5页 Chinese Pharmaceutical Journal
关键词 柑桔类果汁 阿托伐他汀 药动学 mandarin orange juice atorvastatin pharmacokinetics
  • 引文网络
  • 相关文献

参考文献10

  • 1CHONG P H, SEEGER J D,FRANKLIN C. Clinically relevant differences between the statlns:implications for therapeutic selection[J]. Am J Med , 2001,111(2) :390-400.
  • 2FUKAZAWA I, UCHIDA N, UCHIDA E, et al. Effect of grapefruit juice on pharmacokinetics of atorvastatin and pravastatin in Japanese[J]. Br J Clin Pharmacol, 2003,57 (4) : 448-455.
  • 3HERMANN M, CHRISTENSEN H, REUBSAET J f, E. Deterruination of atorvastatin and metabolites in human plasma with solid-phase extraction followed by LC-tandem MS[ J]. Anal Bioanal Chem, 2005,382 (10) :1242-1249.
  • 4TASSANEEYAKUL W, GUO L Q, FUKUDA K, et al. Inhibition selectivity of grapefruit juice components on human cytochromes P450 [ J ]. Arch Biochem Biophys, 2000,378 ( 5 ) : 356- 363.
  • 5EDWARDS D J, FITZSIMMONS M E, SCHUETZ E G, et al. 6' ,7'-Dihydroxybergamottin in grapefruit juice and seville orange juice: Effect on cycosporine, enterocyte CYP3Ad, and P-glycoprotein [ J ]. Clin Pharmacol Ther, 1999,65 (3) : 237-244.
  • 6WANG E, CASCIANO C N, CLEMENT R P, et al. HNG-CoA reductase inhibitors(statins) characterized as direct inhibltors of P-glycoprotein [ J ]. Pharm Res, 2001,18 (2) : 800-806.
  • 7LILJA J J,KIVISTO K T,NEUVONEN P J. Grapefruit juice increases serum concentration of atorvastatin and no effect on pravastatin[J]. Clin Pharmacol Ther , 1999,66(4):118-127.
  • 8HOP C, SAVILLE D J, COVILLE P F, et al. Content of CYP3A4 inhibitors, naringin, naringenin and bergapten in grapefruit and grapefruit juice products[ J 1. Pharm Acta Helv, 2000, 74(4) :379-385.
  • 9HERMANN M, ASBERG A, CHRISTENSEN H, et al. Substantially elevated levels of atorvastatin and metabolites in cyclosporine-treated renal transplant recipients [ J ]. Clin Pharmacol Ther, 2004,76 (4) :388-391.
  • 10TERRY A, JACOBSON M D. Comparative pharmacokinetic interaction profiles of pravastatin, simvastatin, and atorvastatin when coadministered with cytochrome P450 inhibitors[ J]. Am J Cardiol, 2004,94 (9) :1140-1146.

相关主题

;
使用帮助 返回顶部